Machine Learning in Cardiology: A Potential Real-World Solution in Low- and Middle-Income Countries

Artificial intelligence (AI) and machine learning (ML) is a promising field of cardiovascular medicine. Many AI tools have been shown to be efficacious with a high level of accuracy. Yet, their use in real life is not well established. In the era of health technology and data science, it is crucial...

Full description

Saved in:
Bibliographic Details
Published in:Journal of multidisciplinary healthcare 2023-01, Vol.16, p.285-295
Main Authors: Alabdaljabar, Mohamad S, Hasan, Babar, Noseworthy, Peter A, Maalouf, Joseph F, Ammash, Naser M, Hashmi, Shahrukh K
Format: Article
Language:English
Subjects:
Artificial intelligence
Cardiology
Cardiovascular agents
Cardiovascular diseases
Coronaviruses
countries
COVID-19
Fatalities
Health care
Health care reform
income
low
Machine learning
middle
Review
Software
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Artificial intelligence (AI) and machine learning (ML) is a promising field of cardiovascular medicine. Many AI tools have been shown to be efficacious with a high level of accuracy. Yet, their use in real life is not well established. In the era of health technology and data science, it is crucial to consider how these tools could improve healthcare delivery. This is particularly important in countries with limited resources, such as low- and middle-income countries (LMICs). LMICs have many barriers in the care continuum of cardiovascular diseases (CVD), and big portion of these barriers come from scarcity of resources, mainly financial and human power constraints. AI/ML could potentially improve healthcare delivery if appropriately applied in these countries. Expectedly, the current literature lacks original articles about AI/ML originating from these countries. It is important to start early with a stepwise approach to understand the obstacles these countries face in order to develop AI/ML-based solutions. This could be detrimental to many patients' lives, in addition to other expected advantages in other sectors, including the economy sector. In this report, we aim to review what is known about AI/ML in cardiovascular medicine, and to discuss how it could benefit LMICs.
ISSN:1178-2390
1178-2390
DOI:10.2147/JMDH.S383810